Efipladib is an Orally Active cPLA2α Inhibitor for Inflammation Research
cPLA2α is an intracellular calcium dependent PLA2. It is expressed in a wide variety of tissues and cells. Firstly, cPLA2α can catalyze the release of arachidonic acid (AA) from phospholipids…